(S (NP (JJ Deep) (NNP Learning)) (VP (MD can) (VP (ADVP (RB significantly)) (VB benefit) (NP (NN cancer) (NNS proteomics) (CC and) (NNS genomics)))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP attempt) (S (VP (TO to) (VP (VB determine) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NP (JJ critical) (NNS proteins)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (DT the) (NNP FLT3-ITD) (NN mutation))) (PP (IN in) (NP (JJ newly-diagnosed) (NN acute) (NN myeloid) (NN leukemia) (NNS patients)))))))))))))) (. .))
(NP (NP (DT A) (NNP Deep) (NNP Learning) (NN network)) (VP (VBG consisting) (PP (IN of) (NP (NP (NNS autoencoders)) (VP (VBG forming) (NP (NP (DT a) (JJ hierarchical) (NN model)) (SBAR (WHPP (IN from) (WHNP (WDT which))) (S (NP (NN high-level) (NNS features)) (VP (VBP are) (VP (VBN extracted) (PP (IN without) (NP (JJ labeled) (NN training) (NNS data)))))))))))) (. .))
(S (NP (NNP Dimensional) (NN reduction)) (VP (VBD reduced) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ critical) (NNS proteins)))) (PP (IN from) (NP (CD 231))) (PP (TO to) (NP (CD 20)))) (. .))
(S (NP (NNP Deep) (NNP Learning)) (VP (VBD found) (NP (NP (NP (DT an) (JJ excellent) (NN correlation)) (PP (IN between) (NP (NNP FLT3-ITD) (NN mutation))) (PP (IN with) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (DT these) (CD 20) (JJ critical) (NNS proteins)))))) (PRN (-LRB- -LRB-) (NP (NP (JJ accuracy)) (NP (CD 97) (NN %))) (, ,) (NP (NP (NN sensitivity)) (NP (CD 90) (NN %))) (, ,) (NP (NP (NN specificity)) (NP (CD 100) (NN %))) (-RRB- -RRB-)))) (. .))
(S (NP (PRP$ Our) (NNP Deep) (NNP Learning) (NN network)) (VP (MD could) (VP (VB hone) (PRT (IN in)) (PP (IN on) (NP (NP (CD 20) (NNS proteins)) (PP (IN with) (NP (NP (DT the) (JJS strongest) (NN association)) (PP (IN with) (NP (NNP FLT3-ITD))))))))) (. .))
(S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VP (VB allow) (NP (NP (DT a) (JJ novel) (NN approach)) (SBAR (S (VP (TO to) (VP (VB determine) (NP (NP (JJ critical) (NN protein) (NNS pathways)) (PP (IN in) (NP (DT the) (NNP FLT3-ITD) (NN mutation)))))))))) (, ,) (CC and) (VP (VB provide) (NP (NP (NN proof-of-concept)) (PP (IN for) (NP (NP (DT an) (JJ accurate) (NN approach)) (SBAR (S (VP (TO to) (VP (VB model) (NP (NP (JJ big) (NNS data)) (PP (IN in) (NP (NN cancer) (NNS proteomics) (CC and) (NNS genomics))))))))))))) (. .))
